This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wechalekar AD, Schonland SO, Kastritis E, Gillmore JD, Dimopoulos MA, Lante T et al. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood 2013; 121: 3420–3427.
Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004; 22: 3751–3757.
Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood 2011; 118: 4346–4352.
Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL et al. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant 2014; 49: 434–439.
Hosenpud JD, DeMarco T, Frazier OH, Griffith BP, Uretsky BF, Menkis AH et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation 1991; 84 (5 Suppl): III338–III343.
Dey BR, Chung SS, Spitzer TR, Zheng H, Macgillivray TE, Seldin DC et al. Cardiac transplantation followed by dose-intensive melphalan and autologous stem cell transplantation for light chain amyloidosis and heart failure. Transplantation 2010; 90: 905–911.
Gray GL, Niehaus E, Malhotra R, Ton VK, Watts J, Seldin DC et al. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. J Heart Lung Transplant 2014; 33: 149–156.
Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Kyle RA, Rajkumar SV et al. Autologous stem cell transplant after heart transplant for light chain (AL) amyloid cardiomyopathy. J Heart Lung Transplant 2008; 27: 823–829.
Gillmore JD, Goodman HJ, Lachmann HJ, Offer M, Wechalekar AD, Joshi J et al. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006; 107: 1227–1229.
Varr BC, Liedtke M, Arai S, Lafayette RA, Schrier SL, Wittleles RM . Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. J Heart Lung Transplant 2012; 31: 325–331.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Renteria, A., Sanchorawala, V., Niehaus, E. et al. Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis. Bone Marrow Transplant 50, 868–869 (2015). https://doi.org/10.1038/bmt.2015.9
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.9